Shares of Regeneron Pharmaceuticals advanced on heavy trading volume Friday after reporting 2016 third-quarter earnings above analysts' expectations. Before the market open, the Tarrytown, NY-based biopharmaceutical company reported adjusted earnings of $3.13 per share, beating analysts' estimates of $2.69 a share.
http://ift.tt/2fDJ0ko
No comments:
Post a Comment